|Articles|December 10, 2011
Video blog: HER2-targeted agents
Author(s)Debu Tripathy
Advertisement
Dr. Debu Tripathy explains the HER2 pathway's involvement in breast cancer and how new investigational drugs, including pertuzumab and TDM1, as well as combinations of new and approved drugs are targeting this pathway.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Welireg Plus Keytruda Combination for Adjuvant Treatment of Renal Cell Carcinoma
2
A CAR-T Therapy Is Working Better Than Expected for Patients With Hard to Treat Leukemia
3
From "Not Curable" to "May Be Curable": Joshua Richter, MD, on the New Reality of Multiple Myeloma
4
Your Tumor's Genetic Profile May Not Change Which Treatment Works Best for TNBC
5